世界の多発性筋炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Polymyositis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4732
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、多発性筋炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、アルキル化剤、免疫グロブリン、モノクローナル抗体、コルチコステロイド）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・多発性筋炎治療の市場動向
・企業の競争状況、市場シェア
・多発性筋炎治療の種類別市場規模と予測2016-2027（免疫抑制剤、アルキル化剤、免疫グロブリン、モノクローナル抗体、コルチコステロイド）
・多発性筋炎治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・多発性筋炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・多発性筋炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性筋炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性筋炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性筋炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Hospira, Inc.、Antares Pharma, Inc.、Medexus Pharma, Inc.、Fresenius SE & Co. KGaA、Mylan N.V.、Alcami Corporation、Teva Pharmaceuticals、Novartis AG、Genentech, Inc.）
・結論

Polymyositis (PM) is a type of chronic inflammation of the muscles (inflammatory myopathy) related to dermatomyositis and inclusion body myositis. Its name means “inflammation of many muscles” (poly- + myos- + -itis).

Market Analysis and Insights: Global Polymyositis Treatment Market
The global Polymyositis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Polymyositis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Polymyositis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Polymyositis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Polymyositis Treatment market.

Global Polymyositis Treatment Scope and Market Size
Polymyositis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polymyositis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunosuppressant
Alkylating Agent
Immunoglobulin
Monoclonal Antibodies
Corticosteroids

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Hospira, Inc.
Antares Pharma, Inc.
Medexus Pharma, Inc.
Fresenius SE & Co. KGaA
Mylan N.V.
Alcami Corporation
Teva Pharmaceuticals
Novartis AG
Genentech, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymyositis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressant
1.2.3 Alkylating Agent
1.2.4 Immunoglobulin
1.2.5 Monoclonal Antibodies
1.2.6 Corticosteroids
1.3 Market by Application
1.3.1 Global Polymyositis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Polymyositis Treatment Market Perspective (2016-2027)
2.2 Polymyositis Treatment Growth Trends by Regions
2.2.1 Polymyositis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Polymyositis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Polymyositis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Polymyositis Treatment Industry Dynamic
2.3.1 Polymyositis Treatment Market Trends
2.3.2 Polymyositis Treatment Market Drivers
2.3.3 Polymyositis Treatment Market Challenges
2.3.4 Polymyositis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Polymyositis Treatment Players by Revenue
3.1.1 Global Top Polymyositis Treatment Players by Revenue (2016-2021)
3.1.2 Global Polymyositis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Polymyositis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Polymyositis Treatment Revenue
3.4 Global Polymyositis Treatment Market Concentration Ratio
3.4.1 Global Polymyositis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymyositis Treatment Revenue in 2020
3.5 Polymyositis Treatment Key Players Head office and Area Served
3.6 Key Players Polymyositis Treatment Product Solution and Service
3.7 Date of Enter into Polymyositis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Polymyositis Treatment Breakdown Data by Type
4.1 Global Polymyositis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Polymyositis Treatment Forecasted Market Size by Type (2022-2027)

5 Polymyositis Treatment Breakdown Data by Application
5.1 Global Polymyositis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Polymyositis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Polymyositis Treatment Market Size (2016-2027)
6.2 North America Polymyositis Treatment Market Size by Type
6.2.1 North America Polymyositis Treatment Market Size by Type (2016-2021)
6.2.2 North America Polymyositis Treatment Market Size by Type (2022-2027)
6.2.3 North America Polymyositis Treatment Market Size by Type (2016-2027)
6.3 North America Polymyositis Treatment Market Size by Application
6.3.1 North America Polymyositis Treatment Market Size by Application (2016-2021)
6.3.2 North America Polymyositis Treatment Market Size by Application (2022-2027)
6.3.3 North America Polymyositis Treatment Market Size by Application (2016-2027)
6.4 North America Polymyositis Treatment Market Size by Country
6.4.1 North America Polymyositis Treatment Market Size by Country (2016-2021)
6.4.2 North America Polymyositis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Polymyositis Treatment Market Size (2016-2027)
7.2 Europe Polymyositis Treatment Market Size by Type
7.2.1 Europe Polymyositis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Polymyositis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Polymyositis Treatment Market Size by Type (2016-2027)
7.3 Europe Polymyositis Treatment Market Size by Application
7.3.1 Europe Polymyositis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Polymyositis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Polymyositis Treatment Market Size by Application (2016-2027)
7.4 Europe Polymyositis Treatment Market Size by Country
7.4.1 Europe Polymyositis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Polymyositis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Polymyositis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Polymyositis Treatment Market Size by Type
8.2.1 Asia-Pacific Polymyositis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Polymyositis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Polymyositis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Polymyositis Treatment Market Size by Application
8.3.1 Asia-Pacific Polymyositis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Polymyositis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Polymyositis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Polymyositis Treatment Market Size by Region
8.4.1 Asia-Pacific Polymyositis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Polymyositis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Polymyositis Treatment Market Size (2016-2027)
9.2 Latin America Polymyositis Treatment Market Size by Type
9.2.1 Latin America Polymyositis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Polymyositis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Polymyositis Treatment Market Size by Type (2016-2027)
9.3 Latin America Polymyositis Treatment Market Size by Application
9.3.1 Latin America Polymyositis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Polymyositis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Polymyositis Treatment Market Size by Application (2016-2027)
9.4 Latin America Polymyositis Treatment Market Size by Country
9.4.1 Latin America Polymyositis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Polymyositis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Polymyositis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Polymyositis Treatment Market Size by Type
10.2.1 Middle East & Africa Polymyositis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Polymyositis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Polymyositis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Polymyositis Treatment Market Size by Application
10.3.1 Middle East & Africa Polymyositis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Polymyositis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Polymyositis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Polymyositis Treatment Market Size by Country
10.4.1 Middle East & Africa Polymyositis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Polymyositis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Hospira, Inc.
11.1.1 Hospira, Inc. Company Details
11.1.2 Hospira, Inc. Business Overview
11.1.3 Hospira, Inc. Polymyositis Treatment Introduction
11.1.4 Hospira, Inc. Revenue in Polymyositis Treatment Business (2016-2021)
11.1.5 Hospira, Inc. Recent Development
11.2 Antares Pharma, Inc.
11.2.1 Antares Pharma, Inc. Company Details
11.2.2 Antares Pharma, Inc. Business Overview
11.2.3 Antares Pharma, Inc. Polymyositis Treatment Introduction
11.2.4 Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2016-2021)
11.2.5 Antares Pharma, Inc. Recent Development
11.3 Medexus Pharma, Inc.
11.3.1 Medexus Pharma, Inc. Company Details
11.3.2 Medexus Pharma, Inc. Business Overview
11.3.3 Medexus Pharma, Inc. Polymyositis Treatment Introduction
11.3.4 Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2016-2021)
11.3.5 Medexus Pharma, Inc. Recent Development
11.4 Fresenius SE & Co. KGaA
11.4.1 Fresenius SE & Co. KGaA Company Details
11.4.2 Fresenius SE & Co. KGaA Business Overview
11.4.3 Fresenius SE & Co. KGaA Polymyositis Treatment Introduction
11.4.4 Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2016-2021)
11.4.5 Fresenius SE & Co. KGaA Recent Development
11.5 Mylan N.V.
11.5.1 Mylan N.V. Company Details
11.5.2 Mylan N.V. Business Overview
11.5.3 Mylan N.V. Polymyositis Treatment Introduction
11.5.4 Mylan N.V. Revenue in Polymyositis Treatment Business (2016-2021)
11.5.5 Mylan N.V. Recent Development
11.6 Alcami Corporation
11.6.1 Alcami Corporation Company Details
11.6.2 Alcami Corporation Business Overview
11.6.3 Alcami Corporation Polymyositis Treatment Introduction
11.6.4 Alcami Corporation Revenue in Polymyositis Treatment Business (2016-2021)
11.6.5 Alcami Corporation Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Polymyositis Treatment Introduction
11.7.4 Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2016-2021)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Polymyositis Treatment Introduction
11.8.4 Novartis AG Revenue in Polymyositis Treatment Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Polymyositis Treatment Introduction
11.9.4 Genentech, Inc. Revenue in Polymyositis Treatment Business (2016-2021)
11.9.5 Genentech, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Polymyositis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressant
Table 3. Key Players of Alkylating Agent
Table 4. Key Players of Immunoglobulin
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Corticosteroids
Table 7. Global Polymyositis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Polymyositis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Polymyositis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Polymyositis Treatment Market Share by Regions (2016-2021)
Table 11. Global Polymyositis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Polymyositis Treatment Market Share by Regions (2022-2027)
Table 13. Polymyositis Treatment Market Trends
Table 14. Polymyositis Treatment Market Drivers
Table 15. Polymyositis Treatment Market Challenges
Table 16. Polymyositis Treatment Market Restraints
Table 17. Global Polymyositis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Polymyositis Treatment Market Share by Players (2016-2021)
Table 19. Global Top Polymyositis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polymyositis Treatment as of 2020)
Table 20. Ranking of Global Top Polymyositis Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Polymyositis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Polymyositis Treatment Product Solution and Service
Table 24. Date of Enter into Polymyositis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Polymyositis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Polymyositis Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Polymyositis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Polymyositis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Polymyositis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Polymyositis Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Polymyositis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Polymyositis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Polymyositis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Polymyositis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Polymyositis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Polymyositis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Polymyositis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Polymyositis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Polymyositis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Polymyositis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Polymyositis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Polymyositis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Polymyositis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Polymyositis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Polymyositis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Polymyositis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Polymyositis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Polymyositis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Polymyositis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Polymyositis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Polymyositis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Polymyositis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Polymyositis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Polymyositis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Polymyositis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Polymyositis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Polymyositis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Polymyositis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Polymyositis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Polymyositis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Polymyositis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Polymyositis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Hospira, Inc. Company Details
Table 65. Hospira, Inc. Business Overview
Table 66. Hospira, Inc. Polymyositis Treatment Product
Table 67. Hospira, Inc. Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 68. Hospira, Inc. Recent Development
Table 69. Antares Pharma, Inc. Company Details
Table 70. Antares Pharma, Inc. Business Overview
Table 71. Antares Pharma, Inc. Polymyositis Treatment Product
Table 72. Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 73. Antares Pharma, Inc. Recent Development
Table 74. Medexus Pharma, Inc. Company Details
Table 75. Medexus Pharma, Inc. Business Overview
Table 76. Medexus Pharma, Inc. Polymyositis Treatment Product
Table 77. Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 78. Medexus Pharma, Inc. Recent Development
Table 79. Fresenius SE & Co. KGaA Company Details
Table 80. Fresenius SE & Co. KGaA Business Overview
Table 81. Fresenius SE & Co. KGaA Polymyositis Treatment Product
Table 82. Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 83. Fresenius SE & Co. KGaA Recent Development
Table 84. Mylan N.V. Company Details
Table 85. Mylan N.V. Business Overview
Table 86. Mylan N.V. Polymyositis Treatment Product
Table 87. Mylan N.V. Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 88. Mylan N.V. Recent Development
Table 89. Alcami Corporation Company Details
Table 90. Alcami Corporation Business Overview
Table 91. Alcami Corporation Polymyositis Treatment Product
Table 92. Alcami Corporation Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 93. Alcami Corporation Recent Development
Table 94. Teva Pharmaceuticals Company Details
Table 95. Teva Pharmaceuticals Business Overview
Table 96. Teva Pharmaceuticals Polymyositis Treatment Product
Table 97. Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 98. Teva Pharmaceuticals Recent Development
Table 99. Novartis AG Company Details
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 102. Novartis AG Recent Development
Table 103. Genentech, Inc. Company Details
Table 104. Genentech, Inc. Business Overview
Table 105. Genentech, Inc. Polymyositis Treatment Product
Table 106. Genentech, Inc. Revenue in Polymyositis Treatment Business (2016-2021) & (US$ Million)
Table 107. Genentech, Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polymyositis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressant Features
Figure 3. Alkylating Agent Features
Figure 4. Immunoglobulin Features
Figure 5. Monoclonal Antibodies Features
Figure 6. Corticosteroids Features
Figure 7. Global Polymyositis Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Polymyositis Treatment Report Years Considered
Figure 12. Global Polymyositis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Polymyositis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Polymyositis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Polymyositis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Polymyositis Treatment Market Share by Players in 2020
Figure 17. Global Top Polymyositis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polymyositis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Polymyositis Treatment Revenue in 2020
Figure 19. Global Polymyositis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Polymyositis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Polymyositis Treatment Market Share by Type (2016-2027)
Figure 23. North America Polymyositis Treatment Market Share by Application (2016-2027)
Figure 24. North America Polymyositis Treatment Market Share by Country (2016-2027)
Figure 25. United States Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Polymyositis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Polymyositis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Polymyositis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Polymyositis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Polymyositis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Polymyositis Treatment Market Share by Region (2016-2027)
Figure 41. China Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Polymyositis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Polymyositis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Polymyositis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Polymyositis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Polymyositis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Polymyositis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Polymyositis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Hospira, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 61. Antares Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 62. Medexus Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 63. Fresenius SE & Co. KGaA Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 64. Mylan N.V. Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 65. Alcami Corporation Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 68. Genentech, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の二重特異性モノクローナル抗体市場規模・現状・予測（2021年-2027年） A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antig…
世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年） Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases Market Analysis and Insights: Global Arthritis Monoclonal Antibodies Market The global Arthritis Monoclonal Antibodies market size is project…
世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
バイオシミラーモノクローナル抗体のグローバル市場2021 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…
世界の後腹膜線維症治療市場規模・現状・予測（2021年-2027年） Retroperitoneal fibrosis is the rare disease also known as Ormond’s disease. Retroperitoneal fibrosis is characterized by the inflammatory disorder in which abnormal formation of tissue or fibrosis occurs in the back of the abdominal cavity and behind the retro membrane. This area is known as retrop…